Drugs / EMONO
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02957851 Comparator | Nov 2016 → Aug 2018 | neuralgia | Air Liquide | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMONO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02957851 ↗ |
| Action | Inhibit | “related to the blockade of N-methyl-D-aspartate receptors” PMID 33044394 ↗ Apr 2021 |
| Modality | Other / unclassified | “mostly in the form of an N2O/O2 50%-50% equimolar mixture (EMONO)” PMID 33044394 ↗ Apr 2021 |
| Route | Inhaled | “inhalation of EMONO” PMID 35050957 ↗ Dec 2021 |